Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

36
Number of overlapping holdings
42.4%
% of WDNA's 90 holdings also in XBI
27.1%
% of XBI's 134 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in XBI |
Overlap | |
---|---|---|---|---|
NATERA INC | 4.0% | 2.5% | 2.5% | |
UNITED THERAPEUTICS CORP | 1.8% | 2.3% | 1.8% | |
BLUEPRINT MEDICINES CORP. | 2.5% | 1.7% | 1.7% | |
SAREPTA THERAPEUTICS INC | 1.6% | 2.1% | 1.6% | |
ALNYLAM PHARMACEUTICALS INC | 1.5% | 2.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XBI
NOVOZYMES A/S-B SHARES | 3.5% | |
TWIST BIOSCIENCE CORP. | 3.0% | |
VERICEL CORPORATION | 2.4% | |
ELI LILLY & CO | 2.3% | |
VERACYTE INC | 1.7% | |
NATERA INC | 1.5% | |
GERON CORP | 1.5% | |
NEOGENOMICS INC | 1.5% | |
AGIOS PHARMACEUTICALS INC | 1.5% | |
DANAHER CORP | 1.4% |
WDNA Underweight Relative to XBI
NEUROCRINE BIOSCIENCES INC | -2.8% | |
ABBVIE INC | -2.5% | |
INSMED INC | -2.4% | |
INCYTE CORP | -2.4% | |
VAXCYTE, INC. | -2.3% | |
HALOZYME THERAPEUTICS INC | -2.1% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.9% | |
TG THERAPEUTICS INC | -1.8% | |
MODERNA, INC. | -1.8% | |
VIKING THERAPEUTICS, INC. | -1.5% |